Intercellular Adhesion Molecule-1 as Target for CAR-T-Cell Therapy of Triple-Negative Breast Cancer

Triple-negative breast cancer (TNBC) comprises lethal malignancies with limited treatment options. Chimeric antigen receptor T (CAR-T) cell therapy is an effective immunotherapeutic strategy that has demonstrated unprecedented efficacy in the treatment of hematological malignancies but has shown lim...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Front Immunol
Main Authors: Wei, Heng, Wang, Zeng, Kuang, Yi, Wu, Zhiguo, Zhao, Shasha, Zhang, Zongliang, Li, Hexian, Zheng, Meijun, Zhang, Nan, Long, Cheng, Guo, Wenhao, Nie, Chunlai, Yang, Hui, Tong, Aiping
Formato: Artigo
Idioma:Inglês
Publicado em: Frontiers Media S.A. 2020
Assuntos:
Immunology
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7539633/
https://ncbi.nlm.nih.gov/pubmed/33072116
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fimmu.2020.573823
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados